Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2018-2034)
2.2 Over The Counter (OTC) Drugs Growth Trends by Region
2.2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2018-2023)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2024-2034)
2.3 Over The Counter (OTC) Drugs Market Dynamics
2.3.1 Over The Counter (OTC) Drugs Industry Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2018-2023)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2024
3.5 Over The Counter (OTC) Drugs Key Players Head office and Area Served
3.6 Key Players Over The Counter (OTC) Drugs Product Solution and Service
3.7 Date of Enter into Over The Counter (OTC) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2018-2023)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2024-2034)
5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2018-2023)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2018-2034)
6.2 North America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
6.4 North America Over The Counter (OTC) Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2018-2034)
7.2 Europe Over The Counter (OTC) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
7.4 Europe Over The Counter (OTC) Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2018-2034)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2018-2034)
9.2 Latin America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2018-2034)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.1.5 Bayer AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.2.5 Merck KGaA Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Detail
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.6.5 Alkem Laboratories Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2018-2023)
11.10.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Analgesics
Table 3. Key Players of Dermatology Products
Table 4. Key Players of Gastrointestinal Products
Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)
Table 6. Key Players of Weight Loss/Dietary Products
Table 7. Key Players of Ophthalmic Products
Table 8. Key Players of Sleeping Aids
Table 9. Key Players of Others
Table 10. Global Over The Counter (OTC) Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 11. Global Over The Counter (OTC) Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 12. Global Over The Counter (OTC) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Over The Counter (OTC) Drugs Market Share by Region (2018-2023)
Table 14. Global Over The Counter (OTC) Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 15. Global Over The Counter (OTC) Drugs Market Share by Region (2024-2034)
Table 16. Over The Counter (OTC) Drugs Market Trends
Table 17. Over The Counter (OTC) Drugs Market Drivers
Table 18. Over The Counter (OTC) Drugs Market Challenges
Table 19. Over The Counter (OTC) Drugs Market Restraints
Table 20. Global Over The Counter (OTC) Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Over The Counter (OTC) Drugs Market Share by Players (2018-2023)
Table 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2024)
Table 23. Ranking of Global Top Over The Counter (OTC) Drugs Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Over The Counter (OTC) Drugs Product Solution and Service
Table 27. Date of Enter into Over The Counter (OTC) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Over The Counter (OTC) Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2018-2023)
Table 31. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 32. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2024-2034)
Table 33. Global Over The Counter (OTC) Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2018-2023)
Table 35. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 36. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2024-2034)
Table 37. North America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. North America Over The Counter (OTC) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Over The Counter (OTC) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Europe Over The Counter (OTC) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Over The Counter (OTC) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 43. Asia-Pacific Over The Counter (OTC) Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 44. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 46. Latin America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Latin America Over The Counter (OTC) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Over The Counter (OTC) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 49. Middle East & Africa Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 50. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 52. Bayer AG Company Detail
Table 53. Bayer AG Business Overview
Table 54. Bayer AG Over The Counter (OTC) Drugs Product
Table 55. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 56. Bayer AG Recent Development
Table 57. Merck KGaA Company Detail
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Over The Counter (OTC) Drugs Product
Table 60. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 61. Merck KGaA Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Over The Counter (OTC) Drugs Product
Table 65. Novartis Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Johnson & Johnson Company Detail
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Over The Counter (OTC) Drugs Product
Table 70. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Over The Counter (OTC) Drugs Product
Table 75. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Alkem Laboratories Company Detail
Table 78. Alkem Laboratories Business Overview
Table 79. Alkem Laboratories Over The Counter (OTC) Drugs Product
Table 80. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 81. Alkem Laboratories Recent Development
Table 82. Teva Pharmaceutical Industries Company Detail
Table 83. Teva Pharmaceutical Industries Business Overview
Table 84. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product
Table 85. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Recent Development
Table 87. Pfizer Company Detail
Table 88. Pfizer Business Overview
Table 89. Pfizer Over The Counter (OTC) Drugs Product
Table 90. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Sun Pharma Company Detail
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Over The Counter (OTC) Drugs Product
Table 95. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 96. Sun Pharma Recent Development
Table 97. Allergan Company Detail
Table 98. Allergan Business Overview
Table 99. Allergan Over The Counter (OTC) Drugs Product
Table 100. Allergan Revenue in Over The Counter (OTC) Drugs Business (2018-2023) & (US$ Million)
Table 101. Allergan Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over The Counter (OTC) Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Over The Counter (OTC) Drugs Market Share by Type: 2024 VS 2034
Figure 3. Analgesics Features
Figure 4. Dermatology Products Features
Figure 5. Gastrointestinal Products Features
Figure 6. Vitamins, Mineral, and Supplements (VMS) Features
Figure 7. Weight Loss/Dietary Products Features
Figure 8. Ophthalmic Products Features
Figure 9. Sleeping Aids Features
Figure 10. Others Features
Figure 11. Global Over The Counter (OTC) Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 12. Global Over The Counter (OTC) Drugs Market Share by Application: 2024 VS 2034
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Retail Pharmacies Case Studies
Figure 15. Online Pharmacy Case Studies
Figure 16. Others Case Studies
Figure 17. Over The Counter (OTC) Drugs Report Years Considered
Figure 18. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 19. Global Over The Counter (OTC) Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 20. Global Over The Counter (OTC) Drugs Market Share by Region: 2024 VS 2034
Figure 21. Global Over The Counter (OTC) Drugs Market Share by Players in 2024
Figure 22. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2024
Figure 24. North America Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. North America Over The Counter (OTC) Drugs Market Share by Country (2018-2034)
Figure 26. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Europe Over The Counter (OTC) Drugs Market Share by Country (2018-2034)
Figure 30. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. France Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Nordic Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Region (2018-2034)
Figure 38. China Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. India Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Latin America Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Latin America Over The Counter (OTC) Drugs Market Share by Country (2018-2034)
Figure 46. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Country (2018-2034)
Figure 50. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 53. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 57. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 60. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 61. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed